EPHA4 and amyotrophic lateral sclerosis: In comparison, heterozygous deletion of EphA4 may be insufficient to induce compensatory mechanisms resulting in a reduced level of EphA4, which would maintain normal CNS function and protecting motor neurons from death in ALS progression.